The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Key developments at portfolio company Alusid

5 Feb 2015 07:00

RNS Number : 0922E
Frontier IP Group plc
05 February 2015
 



 

 

AIM: FIPP

5th February 2015 

 

Frontier IP Group Plc

("Frontier IP")

 

Key developments at portfolio company Alusid

 

Frontier IP, which specialises in the commercialisation of university intellectual property, is pleased to announce a number of new developments at its portfolio company Alusid Ltd ("Alusid"). In preparation for the next phase of Alusid's commercialisation, Alusid has completed a corporate restructuring, secured the IP needed, signed its first industrial partner and appointed a Chairman. Frontier IP's beneficial ownership of Alusid has increased to 46% of the issued share capital of Alusid following the company's corporate restructuring, up from 30%.

 

Alusid, a spin-out from the Silicate Research Unit of University of Central Lancashire ("UCLan"), was formed to commercialise technology developed by UCLan and a licence agreement has now been signed with UCLan enabling Alusid to exploit the technology commercially. This innovative technology enables industrial waste materials to be turned into environmentally sustainable materials suitable for use in the global construction industry, a significant addressable market. In line with its manufacturing plan, Alusid has entered into an agreement with Recycling Lives Limited ("Recycling Lives"), for the supply of recyclable raw materials, plant and labour. Recycling Lives, based in Lancashire, has some forty years' experience in recycling and has twice received the Queen's Award for Enterprise in Sustainable Development.

 

In addition, Alusid's management team has been strengthened with the appointment of Anthony Attard OBE as Chairman. Tony has considerable experience of both the construction and interiors industries and is currently Chairman of an established building construction business.

 

In order to accelerate its commercialisation Alusid intends, with the support of Frontier IP, to seek its first round of funding over the coming months.

 

Paul Finnerty, Recycling Lives Limited said:

 

"Recycling Lives is pleased to be working with Alusid and we look forward to supporting the growth of its business. We expect Alusid to become a key outlet for our waste glass and ceramic material and, as we are a significant recycler of screens, we look forward in particular to Alusid applying its novel process to our Cathode Ray Tube (CRT) screen waste. The product is a welcome addition to the industry where there are currently few viable and cost-effective outlets for leaded CRT glass. In achieving end of waste status, Alusid is well placed to succeed in this competitive business."

 

John Lonsdale, University of Central Lancashire said:

 

"UCLan is delighted to be contributing expertise to Alusid, whose products combine aesthetically pleasing product design with excellent green credentials. It is a great example of how, with the right team, research can be taken to market to provide exciting new products. "

 

Neil Crabb, Chief Executive of Frontier IP said:

 

"Alusid has a very exciting "green" technology with strong commercial potential. We look forward to working with the Alusid team as it embarks on this crucial phase of its development."

 

Enquiries

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

T: 020 7894 7000

Mark Percy / Catherine Leftley, Corporate Finance

David Banks, Corporate Broking

Peterhouse Corporate Finance Limited (Joint Broker)

T: 020 7469 0935

Lucy Williams

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis / Deborah Walter

 

 

Notes to Editor:

 

Frontier IP Group plc

www.frontierip.co.uk.

Frontier IP specialises in assisting universities, research institutions and companies in the commercialisation and exploitation of their Intellectual Property.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSOWRVBAURAR
Date   Source Headline
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project
30th Nov 20225:00 pmRNSTotal Voting Rights
25th Nov 20222:23 pmRNSDirector/PDMR Shareholding
23rd Nov 20225:17 pmRNSDirector share transfers
18th Nov 20223:53 pmRNSExercise of Options & PDMR Shareholdings
11th Nov 20223:07 pmRNSDirector/PDMR Dealing
11th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
8th Nov 20227:00 amRNSPulsiv announces £1.5m fundraise
1st Nov 20221:46 pmEQSFrontier IP Group 'rigged for a storm' but confident of more progress
27th Oct 20227:00 amRNSFinal Results
19th Oct 20224:22 pmRNSHolding(s) in Company
19th Oct 20223:29 pmRNSHolding(s) in Company
14th Oct 20227:00 amRNSElute Intelligence appoints Steve Cable as CEO
27th Sep 20227:00 amRNSPulsiv unveils power electronics technology
18th Aug 20223:20 pmRNSSale of shares in Exscientia
5th Aug 20227:00 amRNSCamGraPhIC announces £1.26 million fundraising
26th Jul 20224:26 pmRNSHolding(s) in Company
26th Jul 20224:07 pmRNSHolding(s) in Company
24th May 20227:00 amRNSCambridge Raman Imaging raises £1.1 million
19th May 20227:00 amRNSPublication of newsletter
12th Apr 20225:18 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSUnaudited Half Year Results
14th Feb 20227:00 amRNSSale of shares in Exscientia
11th Feb 20225:04 pmRNSHolding(s) in Company
11th Feb 20222:05 pmRNSHolding(s) in Company
10th Feb 20227:00 amRNSCambridge Raman Imaging wins European Union grant
25th Jan 20227:00 amRNSSale of shares in Exscientia
17th Jan 20225:56 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSTrading update
11th Jan 20227:00 amRNSCelerum launch first commercial product
9th Dec 20212:33 pmRNSResult of AGM
29th Nov 20217:00 amRNSTVG - milestone in development of COVID-19 vaccine
9th Nov 20217:00 amRNSPosting of Annual Accounts and Notice of AGM
28th Oct 20217:00 amRNSDirectorate Change
28th Oct 20217:00 amRNSFinal Results
15th Oct 20217:00 amRNSPublication of newsletter
1st Oct 20217:59 amRNSPricing of IPO of Exscientia in the United States
30th Sep 20217:00 amRNSCamGraPhIC raises £1.6 million
27th Sep 20213:56 pmRNSUpdate on proposed IPO of Exscientia
24th Sep 20217:00 amRNSHolding(s) in Company
13th Sep 20217:00 amRNSExscientia - Statement filed for proposed IPO
8th Sep 20211:24 pmRNSExscientia enters $70M collaboration
8th Jul 20217:00 amRNSCamGraPhIC loan facility of up to £1.5 million
15th Jun 20217:00 amRNSPulsiv appoints Adam Westcott as CFO
14th Jun 20217:00 amRNSNandi Proteins appoints David Flower as CEO
11th Jun 20217:00 amRNSPublication of newsletter
24th May 20217:00 amRNSPulsiv complete £1.5m fundraising and appoints CEO
19th May 202111:53 amRNSExscientia collaboration with Bristol Myers Squibb
6th May 20217:00 amRNSThe Vaccine Group appoints Jeremy Salt as CEO
30th Apr 20211:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.